DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
DaVita (NYSE: DVA) will hold its third-quarter 2026 results conference call on October 29, 2026, at 5:00 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DaVita (NYSE: DVA) will hold its third-quarter 2026 results conference call on October 29, 2026, at 5:00 p.m. Eastern Time. The company plans to release results after market close that day. The call will be webcast through DaVita's investor relations website, where a replay will also be available. There will be no telephone replay.
AI-generated analysis. How Rhea-AI works. Not financial advice.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Thursday, October 29, 2026
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (NYSE: DVA) is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey — from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of June 30, 2026, DaVita served approximately 298,500 patients at 3,266 outpatient dialysis centers, of which 2,671 centers were located in the United States and 595 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:

View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-3rd-quarter-2026-investor-conference-call-302913178.html
SOURCE DaVita